|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4745 | |
| A61K 39/00 |
| (11) | Number of the document | 2376082 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09795585.0 |
| Date of filing the European patent application | 2009-12-15 | |
| (97) | Date of publication of the European application | 2011-10-19 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/006560 |
| Date | 2009-12-15 |
| (87) | Number | WO 2010/074724 |
| Date | 2010-07-01 |
| (30) | Number | Date | Country code |
| 203509 P | 2008-12-22 | US |
| (72) |
MANFREDI, Mark, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | COMBINATION OF AURORA KINASE INHIBITORS AND ANTI-CD20 ANTIBODIES |
| COMBINATION OF AURORA KINASE INHIBITORS AND ANTI-CD20 ANTIBODIES |